Deutsche Bank Ag\ Arcutis Biotherapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 800,027 shares of ARQT stock, worth $11.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

800,027

Previous 1,882,025 57.49%

Holding current value

$11.9 Million

Previous $17.5 Million 57.49%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$8.32 - $11.0 $9 Million - $11.9 Million	-1,081,998 Reduced 57.49%	800,027 $7.44 Million
Q2 2024 Aug 14, 2024	BUY	$7.24 - $12.53 $68,200 - $118,032	9,420 Added 0.5%	1,882,025 $17.5 Million
Q1 2024 May 15, 2024	BUY	$3.25 - $11.77 $1.55 Million - $5.63 Million	478,195 Added 34.29%	1,872,605 $18.6 Million
Q4 2023 Feb 14, 2024	BUY	$1.84 - $4.82 $2.51 Million - $6.57 Million	1,364,048 Added 4492.62%	1,394,410 $4.5 Million
Q3 2023 Nov 09, 2023	BUY	$5.31 - $10.98 $19,408 - $40,131	3,655 Added 13.69%	30,362 $161,000
Q2 2023 Aug 14, 2023	SELL	$7.51 - $15.0 $71,990 - $143,790	-9,586 Reduced 26.41%	26,707 $254,000
Q1 2023 May 15, 2023	BUY	$10.23 - $17.14 $113,767 - $190,613	11,121 Added 44.18%	36,293 $399,000
Q4 2022 Feb 13, 2023	BUY	$13.96 - $20.4 $97,273 - $142,147	6,968 Added 38.28%	25,172 $372,000
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $9,906 - $14,957	555 Added 3.14%	18,204 $348,000
Q2 2022 Aug 11, 2022	BUY	$16.33 - $22.2 $40,139 - $54,567	2,458 Added 16.18%	17,649 $376,000
Q1 2022 May 13, 2022	SELL	$14.38 - $22.79 $25,567 - $40,520	-1,778 Reduced 10.48%	15,191 $293,000
Q4 2021 Feb 11, 2022	BUY	$14.98 - $25.5 $13,212 - $22,491	882 Added 5.48%	16,969 $352,000
Q3 2021 Nov 04, 2021	SELL	$19.28 - $27.1 $37,518 - $52,736	-1,946 Reduced 10.79%	16,087 $384,000
Q2 2021 Aug 11, 2021	BUY	$24.42 - $34.75 $34,871 - $49,623	1,428 Added 8.6%	18,033 $492,000
Q1 2021 May 13, 2021	SELL	$24.47 - $36.98 $2.43 Million - $3.67 Million	-99,330 Reduced 85.68%	16,605 $480,000
Q4 2020 Feb 16, 2021	BUY	$17.82 - $31.73 $1.89 Million - $3.37 Million	106,120 Added 1081.2%	115,935 $3.26 Million
Q3 2020 Nov 12, 2020	BUY	$23.44 - $32.28 $119,309 - $164,305	5,090 Added 107.72%	9,815 $288,000
Q2 2020 Aug 13, 2020	BUY	$24.48 - $36.56 $26,120 - $39,009	1,067 Added 29.17%	4,725 $143,000
Q1 2020 May 14, 2020	BUY	$18.5 - $36.9 $67,673 - $134,980	3,658 New	3,658 $109,000

Others Institutions Holding ARQT

# of Institutions

197

Shares Held

129M

Call Options Held

738K

Put Options Held

82K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $894M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account